Navigation Links
Drugs disrupt formation of blood vessels

Scientists have made a signficant step forward in their attempt to starve cancer tumours by stopping the growth of the blood vessels that feed them nutrients. Four drugs that disrupt angiogenesis - blood vessel formation - have been shown for the first time to be effective. It also provides the first indication that the drugs, known as angiogenesis inhibitors, vary in effectiveness depending on the stage of cancer targeted.

// Senior researcher Dr Douglas Hanahan, professor of biochemistry at the University of California in San Francisco, USA, said: " We've shown that these drugs have beneficial effects when used to treat mice developing organ-specific cancer ". The work on mice is significant because scientists believe it closely mirrors the conditions found in human tumours. Mice used in the study were genetically engineered to produce a form of cancer of the pancreas.

The scientists tested drugs to see if they could stop the signals that are emitted to trigger the formation of the blood vessels that fuel the growth of tumours. Four compounds, known as AGM-1470, BB-94, angiostatin and endostatin, together with a combination of the last two, were tested.

They found that if administered early enough all the drugs prevented the tumour from triggering the formation of blood vessels in more than half the cases where it should have occurred. All four drugs were effective, impairing growth by between 60% and 88%. Dr Hanahan said: "Our findings are encouraging about the potential value of angiogenesis inhibitors for treating cancer; we believe we can do even better."


'"/>




Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs to stop burgeon of HIV
7. Misleading Advertisements for Prescription Drugs
8. Drugs For Anthrax May Interfere With Oral Contraceptives
9. Over-The-Counter Drugs May Prevent Alzheimers
10. Steps To Improve Quality Of Plant-Based Drugs
11. Nasal Spray Could Take Drugs Directly to Brain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... December 09, 2016 , ... Flottman ... and outserts. As a means of expanding capabilities Flottman has added a ... to individually code professional inserts (PIs) and patient package inserts (PPIs) that will ...
(Date:12/9/2016)... , ... December 09, 2016 , ... An inventor from ... to safely ride all types of amusement park rides. , The patent-pending SAFETY STRAP ... is easy to use and could be set up in a matter of minutes, ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying ... Va. "I thought that if the nebulizer had a more child-friendly design, then children ... , He developed the patent-pending NEBY to avoid the need to deliver medication via ...
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has ... general counsel and Eric Hoessel to vice president of sales. , Litsinger ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec 9, 2016 Research ... Screening Market - Forecast to 2021" report to their ... ... of open innovative models in the pharmaceutical and biotechnology industry ... and rising government funding. Emerging markets and growing research activities ...
(Date:12/9/2016)...  RxWiki Inc., a digital health company that powers ... thousands of pharmacies through its Digital Pharmacist SaaS platform, ... "50 on Fire" Award in the Health and Life ... the award as one of Austin,s fastest growing companies," ... RxWiki. "Our platform gives independent retail pharmacies the digital ...
(Date:12/9/2016)... , Dec. 9, 2016  Forge Therapeutics, ... AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) ... ,LpxC, for the treatment of bacterial infections including ... been recognized as an attractive antibacterial target for ... lack of suitable chemical starting points has hampered ...
Breaking Medicine Technology: